Whether motivated by the personal journey of a cancer patient or the challenge and rigor of cancer clinical research, at Syneos Health we are passionate about collaborating for a cure.
We are living in a “golden age” for cancer research and discovery. Our knowledge and ability to have direct impact on tumor cells are increasing at a rapid pace, and patients are living longer thanks to advances in genetics, immunotherapy and precision medicine.
Our experts dedicated to oncology and hematology—all 4,400 of us— are collaborating with our customers to change the history of cancer treatments by embracing our customers’ boldest visions and bringing experience, innovation and passion to every oncology program we run.
At Syneos Health, we believe that every clinical trial is an opportunity to shorten the distance from lab to life.